GuruFocus.com5d agoneutral
Novo Nordisk Launches Ozempic Pill in U.S.Oral version targets broader access as GLP-1 demand grows
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Oral version targets broader access as GLP-1 demand grows
Novo will sell 1.5 mg, 4 mg and 9 mg Ozempic pills as it rebrands Rybelsus in the US.